Organic micropollutant removal in a full-scale surface flow constructed wetland fed with secondary effluent.
暂无分享,去创建一个
[1] J. Dabrowski,et al. Fate and effects of azinphos-methyl in a flow through wetland in South Africa. , 2003, Environmental science & technology.
[2] M. Jekel,et al. Organic Pollutants in the Water Cycle: Properties, Occurrence, Analysis and Environmental Relevance of Polar Compounds , 2006 .
[3] R. Schwarzenbach,et al. Environmental Organic Chemistry , 1993 .
[4] Marta Carballa,et al. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. , 2004, Water research.
[5] T. Heberer. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. , 2002, Toxicology letters.
[6] M. Reinhard,et al. Photodegradation of common environmental pharmaceuticals and estrogens in river water , 2005, Environmental toxicology and chemistry.
[7] Adriano Joss,et al. A rapid method to measure the solid-water distribution coefficient (Kd) for pharmaceuticals and musk fragrances in sewage sludge. , 2004, Water research.
[8] A. E. Greenberg,et al. Standard methods for the examination of water and wastewater : supplement to the sixteenth edition , 1988 .
[9] Watze de Wolf,et al. Removal of fragrance materials during U.S. and European wastewater treatment. , 2002, Environmental science & technology.
[10] M. Alexander. How toxic are toxic chemicals in soil? , 1995, Environmental science & technology.
[11] Thomas Heberer,et al. Tracking persistent pharmaceutical residues from municipal sewage to drinking water , 2002 .
[12] Roberto Andreozzi,et al. Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. , 2003, Chemosphere.
[13] J. Bayona,et al. Elimination of pharmaceuticals and personal care products in subsurface flow constructed wetlands. , 2006, Environmental science & technology.
[14] Ole Christian Hansen,et al. Quantitative Structure-Activity Relationships (QSAR) and Pesticides , 2004 .
[15] G G Rimkus,et al. Polycyclic musk fragrances in the aquatic environment. , 1999, Toxicology letters.
[16] S. Cole. The emergence of treatment wetlands. , 1998, Environmental science & technology.
[17] Jaume Puigagut,et al. Behavior of selected priority organic pollutants in horizontal subsurface flow constructed wetlands: a preliminary screening. , 2007, Chemosphere.
[18] Christian Zwiener,et al. Oxidative treatment of pharmaceuticals in water , 2000 .
[19] G. Lyberatos,et al. Fate and mobility of pharmaceuticals in solid matrices. , 2005, Chemosphere.
[20] G. Duca,et al. Pharmaceuticals and Personal Care Products in the Environment , 2009 .
[21] M. Birkved,et al. Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use. , 2000, Chemosphere.
[22] A Pressl,et al. Evaluation of substrate clogging processes in vertical flow constructed wetlands. , 2003, Water science and technology : a journal of the International Association on Water Pollution Research.
[23] K. Kimura,et al. Removal of pharmaceutical compounds by submerged membrane bioreactors (MBRs) , 2005 .
[24] F. Frimmel,et al. Short-term tests with a pilot sewage plant and biofilm reactors for the biological degradation of the pharmaceutical compounds clofibric acid, ibuprofen, and diclofenac. , 2003, The Science of the total environment.
[25] J. Bayona,et al. Behavior of selected pharmaceuticals in subsurface flow constructed wetlands: a pilot-scale study. , 2005, Environmental science & technology.
[26] E. Bouwer,et al. Occurrence and biodegradability studies of selected pharmaceuticals and personal care products in sewage effluent , 2006 .
[27] R A Ford,et al. Environmental risk assessment for the polycyclic musks AHTN and HHCB in the EU. I. Fate and exposure assessment. , 1999, Toxicology letters.
[28] J. Santos,et al. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain). , 2007, Environment international.
[29] J. Müller,et al. Biodegradation of persistent polar pollutants in wastewater: comparison of an optimised lab-scale membrane bioreactor and activated sludge treatment. , 2006, Water research.
[30] A. Boxall,et al. Are veterinary medicines causing environmental risks? , 2003, Environmental science & technology.
[31] M. Reinhard,et al. Occurrence and fate of pharmaceuticals and alkylphenol ethoxylate metabolites in an effluent‐dominated river and wetland , 2004, Environmental toxicology and chemistry.
[32] Damià Barceló,et al. Factors affecting linear alkylbenzene sulfonates removal in subsurface flow constructed wetlands. , 2004, Environmental science & technology.
[33] Christian G. Daughton,et al. Pharmaceuticals and Care Products in the Environment: Scientific and Regulatory Issues , 2001 .
[34] Adriano Joss,et al. Scrutinizing pharmaceuticals and personal care products in wastewater treatment. , 2004, Environmental science & technology.
[35] C. Daughton. Non-regulated water contaminants: emerging research , 2004 .
[36] Johanne Beausse,et al. Selected drugs in solid matrices: a review of environmental determination, occurrence and properties of principal substances , 2004 .
[37] D. Mara,et al. Guidelines for the Safe Use of Wastewater and Excreta in Agriculture and Aquaculture: Measures for Public Health Protection , 1989 .
[38] Martin Kampmann,et al. Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater? , 2003, Water research.
[39] C. M. Cooper,et al. Mitigation of chlorpyrifos runoff using constructed wetlands. , 2002, Chemosphere.